Brief: Beam Therapeutics Reports Third Quarter 2024 Financial Results And Progress Across Priority Programs
05/11/2024 11:37
Nov 5 (Reuters) - Beam Therapeutics Inc BEAM.O :
* BEAM THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROGRESS ACROSS PRIORITY PROGRAMS
* BEAM THERAPEUTICS INC - EXPECTED OPERATING RUNWAY INTO
2027
* BEAM THERAPEUTICS INC: QTRLY LOSS PER SHARE $1.17
Source text: ID:nGNX9Q0m5K
Further company coverage: BEAM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta